|
2,120
|
| 17344 |
P. aeruginosa infection
|
|
affects_activity of
|
Acyl-HSL quorum sensing
|
|
|
10922036
|
Pseudomonas aeruginosa diseases
|
|
2,123
|
| 17426 |
P. aeruginosa infection
|
|
increases_activity of
|
Pneumonia
|
|
| 17527 |
P. aeruginosa infection
|
|
increases_activity of
|
T3SS
|
|
| 17553 |
P. aeruginosa infection
|
|
affects_activity of
|
Acyl-HSL quorum sensing
|
|
| 17557 |
P. aeruginosa infection
|
|
increases_activity of
|
biofilm formation
|
|
| 17584 |
P. aeruginosa infection
|
|
increases_quantity of
|
Pyochelin
|
|
| 17585 |
P. aeruginosa infection
|
|
increases_quantity of
|
Pyoverdine I
|
|
| 17678 |
P. aeruginosa infection
|
|
increases_quantity of
|
Pyocyanine
|
|
| 17724 |
P. aeruginosa infection
|
|
increases_activity of
|
SMPD1
|
|
| 17732 |
P. aeruginosa infection
|
|
increases_activity of
|
pseudopodium assembly
|
|
| 17762 |
P. aeruginosa infection
|
|
increases_activity of
|
immune response
|
|
| 17775 |
P. aeruginosa infection
|
|
increases_activity of
|
TLR4
|
|
| 17784 |
IL18
|
|
increases_activity of
|
P. aeruginosa infection
|
|
| 17792 |
IL10
|
|
decreases_activity of
|
P. aeruginosa infection
|
|
| 17794 |
IL4
|
|
decreases_activity of
|
P. aeruginosa infection
|
|
| 17830 |
SDC1
|
|
increases_activity of
|
P. aeruginosa infection
|
|
| 24258 |
T-helper 1 type immune response
|
|
decreases_activity of
|
P. aeruginosa infection
|
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,210
|
| 18886 |
P. aeruginosa infection
|
|
increases_quantity of
|
cis-2-Decenoic acid
|
biofilm dispersion
|
| 18942 |
P. aeruginosa infection
|
|
increases_quantity of
|
rhamnolipid
|
|
|
20370936
|
Pseudomonas aeruginosa diseases
|
|
2,214
|
| 18646 |
Anthranilate
|
|
affects_activity of
|
P. aeruginosa infection
|
|
|
18704225
|
Pseudomonas aeruginosa diseases
|
|
2,242
|
| 19179 |
P. aeruginosa infection
|
|
increases_quantity of
|
Pyocyanine
|
|
|
19196266
|
Pseudomonas aeruginosa diseases
|
|
2,285
|
| 19479 |
pqsE
|
|
affects_activity of
|
P. aeruginosa infection
|
|
|
20738404
|
Pseudomonas aeruginosa diseases
|
|
2,336
|
| 20389 |
CBLB
|
|
decreases_activity of
|
P. aeruginosa infection
|
|
|
19680249
|
Pseudomonas aeruginosa diseases
|
|
2,363
|
| 20781 |
Long-chain fatty acid
|
|
affects_activity of
|
P. aeruginosa infection
|
|
|
19508282
|
Pseudomonas aeruginosa diseases
|
|
2,377
|
| 20864 |
P. aeruginosa infection
|
|
increases_expression of
|
CTGF
|
|
| 20867 |
P. aeruginosa infection
|
|
increases_expression of
|
CYR61
|
|
|
17765657
|
Pseudomonas aeruginosa diseases
|
|
2,464
|
| 22792 |
P. aeruginosa infection
|
|
increases_activity of
|
T1SS (Apr)
|
Apr genes T1SS system
|
| 22793 |
P. aeruginosa infection
|
|
increases_activity of
|
T1SS (Has)
|
Has genes T1SS system
|
| 22794 |
P. aeruginosa infection
|
|
increases_activity of
|
T2SS (Xcp)
|
|
| 22795 |
P. aeruginosa infection
|
|
increases_activity of
|
T3SS
|
|
| 22796 |
P. aeruginosa infection
|
|
increases_activity of
|
T5SS
|
|
| 24082 |
P. aeruginosa infection
|
|
increases_activity of
|
T6SS-HSI-2
|
|
| 24083 |
P. aeruginosa infection
|
|
increases_activity of
|
T6SS-HSI-3
|
|
| 26940 |
P. aeruginosa infection
|
|
increases_activity of
|
T2SS (Hxc)
|
|
|
20947426
|
Pseudomonas aeruginosa diseases
|
|
2,504
|
| 23316 |
P. aeruginosa infection
|
|
increases_activity of
|
ABL1
|
|
| 23324 |
P. aeruginosa infection
|
|
increases_activity of
|
ABL2
|
|
| 23329 |
P. aeruginosa infection
|
|
affects_activity of
|
RAC1
|
|
| 23330 |
P. aeruginosa infection
|
|
affects_activity of
|
CDC42
|
|
|
18369477
|
Pseudomonas aeruginosa diseases
|
|
2,545
|
| 23699 |
P. aeruginosa infection
|
|
increases_activity of
|
p38 MAPK
|
|
|
19064995
|
Pseudomonas aeruginosa diseases
|
|
2,586
|
| 24363 |
P. aeruginosa infection
|
|
increases_activity of
|
T3SS
|
in ameba, insect, zebrafish, and mammalian infection models
|
|
21833328
|
Pseudomonas aeruginosa diseases
|
|
2,612
|
| 24753 |
rhlR
|
|
increases_activity of
|
P. aeruginosa infection
|
in a Drosophila melanogaster oral infection model
|
| 24761 |
lasR
|
NOT |
affects_activity of
|
P. aeruginosa infection
|
in a Drosophila melanogaster oral infection model
|
|
21987808
|
Pseudomonas aeruginosa diseases
|
|
2,613
|
| 24783 |
P. aeruginosa infection
|
|
increases_expression of
|
BDKRB2
|
|
| 24791 |
P. aeruginosa infection
|
|
increases_quantity of
|
BDKRB2
|
|
| 24794 |
P. aeruginosa infection
|
|
increases_quantity of
|
Bradykinin
|
|
| 24834 |
P. aeruginosa infection
|
|
increases_activity of
|
I-kappaB kinase/NF-kappaB signaling
|
|
|
21626144
|
Pseudomonas aeruginosa diseases
|
|
2,742
|
| 25395 |
P. aeruginosa infection
|
|
increases_expression of
|
BDKRB1
|
in airway epithelial A549 cells; optimum reached at 4 h post treatment at an MOI of 10
|
| 25397 |
P. aeruginosa infection
|
|
increases_quantity of
|
BDKRB1
|
in airway epithelial A549 cells; 4 h post treatment
|
| 25400 |
P. aeruginosa infection
|
|
increases_activity of
|
I-kappaB kinase/NF-kappaB signaling
|
|
|
22092568
|
Pseudomonas aeruginosa diseases
|
|
2,745
|
| 25404 |
P. aeruginosa infection
|
|
increases_quantity of
|
Prostaglandin E2
|
in A549 cells; after 3 h infection
|
| 25405 |
P. aeruginosa infection
|
|
increases_quantity of
|
Hepoxilin A3
|
in A549 cells; after 3 h infection
|
| 25406 |
P. aeruginosa infection
|
|
increases_quantity of
|
Arachidonic acid
|
|
| 25414 |
P. aeruginosa infection
|
|
increases_activity of
|
PLA2G4A
|
by phosphorylation
|
|
21097525
|
Pseudomonas aeruginosa diseases
|
|
2,790
|
| 25800 |
P. aeruginosa infection
|
|
increases_quantity of
|
Ca2+
|
in lung epithelia
|
| 25804 |
P. aeruginosa infection
|
|
increases_activity of
|
FBXL2
|
|
| 25813 |
CALM1
|
|
decreases_activity of
|
P. aeruginosa infection
|
|
|
21343341
|
Pseudomonas aeruginosa diseases
|
|
2,802
|
| 25857 |
P. aeruginosa infection
|
|
increases_activity of
|
cell death
|
in macrophages; infected with P. aeruginosa strain PAK (ExoU deficient)
|
|
18070936
|
Pseudomonas aeruginosa diseases
|
|
2,813
|
| 25923 |
P. aeruginosa infection
|
|
increases_activity of
|
cellular response to DNA damage stimulus
|
|
| 25924 |
P. aeruginosa infection
|
|
increases_quantity of
|
7,8-Dihydro-8-oxoguanine
|
|
| 25927 |
P. aeruginosa infection
|
|
increases_activity of
|
OGG1
|
|
| 25928 |
P. aeruginosa infection
|
|
increases_activity of
|
APEX1
|
|
| 25929 |
P. aeruginosa infection
|
|
increases_activity of
|
ERCC6
|
|
| 25930 |
P. aeruginosa infection
|
|
increases_quantity of
|
OGG1
|
|
| 25949 |
P. aeruginosa infection
|
|
increases_quantity of
|
APEX1
|
|
| 25964 |
P. aeruginosa infection
|
|
increases_quantity of
|
ERCC6
|
|
| 25968 |
OGG1
|
|
decreases_activity of
|
P. aeruginosa infection
|
|
|
20956573
|
Pseudomonas aeruginosa diseases
|
|
2,818
|
| 25972 |
P. aeruginosa infection
|
|
increases_activity of
|
cellular response to DNA damage stimulus
|
in mouse lungs
|
| 25976 |
P. aeruginosa infection
|
|
increases_quantity of
|
OGG1
|
in mouse lungs
|
| 25978 |
P. aeruginosa infection
|
|
increases_quantity of
|
XRCC1
|
in mouse lungs
|
|
20956573
|
Pseudomonas aeruginosa diseases
|
|
2,853
|
| 29744 |
P. aeruginosa infection
|
|
decreases_expression of
|
copR
|
|
|
21515773
|
Pseudomonas aeruginosa diseases
|
|
2,905
|
| 26636 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL8
|
|
| 26642 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL1
|
|
| 26646 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL2
|
|
| 26650 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL3
|
|
| 26653 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL6
|
|
| 26655 |
P. aeruginosa infection
|
|
increases_expression of
|
CXCL10
|
|
| 26656 |
P. aeruginosa infection
|
|
increases_expression of
|
ICAM1
|
|
| 26658 |
P. aeruginosa infection
|
|
increases_expression of
|
IL1A
|
|
| 26660 |
P. aeruginosa infection
|
|
increases_expression of
|
IL1B
|
|
| 26663 |
P. aeruginosa infection
|
|
increases_expression of
|
IL6
|
|
| 26666 |
P. aeruginosa infection
|
|
increases_expression of
|
TNF
|
|
| 26668 |
P. aeruginosa infection
|
|
increases_expression of
|
TLR2
|
|
| 26672 |
P. aeruginosa infection
|
|
increases_expression of
|
NFKB1
|
|
| 26674 |
P. aeruginosa infection
|
|
increases_expression of
|
HBD-4
|
|
| 26680 |
P. aeruginosa infection
|
|
increases_activity of
|
inflammatory response
|
|
| 26697 |
P. aeruginosa infection
|
|
increases_quantity of
|
N-Acylsphingosine
|
at the plasma membrane
|
|
21659660
|
Pseudomonas aeruginosa diseases
|
|
2,915
|
| 26751 |
P. aeruginosa infection
|
|
increases_quantity of
|
nrdJa
|
|
| 26753 |
P. aeruginosa infection
|
|
increases_quantity of
|
nrdJb
|
|
| 26754 |
P. aeruginosa infection
|
|
increases_quantity of
|
nrdD
|
|
| 26755 |
P. aeruginosa infection
|
|
decreases_quantity of
|
nrdA
|
|
|
21502590
|
Pseudomonas aeruginosa diseases
|
|
2,972
|
| 27075 |
pcrV
|
|
increases_activity of
|
P. aeruginosa infection
|
|
|
21772833
|
Pseudomonas aeruginosa diseases
|
|
3,088
|
| 28343 |
P. aeruginosa infection
|
|
increases_activity of
|
T6SS-HSI-2
|
|
| 28345 |
P. aeruginosa infection
|
|
increases_activity of
|
T6SS-HSI-3
|
|
| 28347 |
P. aeruginosa infection
|
|
increases_activity of
|
T6SS-HSI-1
|
|
|
19497948
|
Pseudomonas aeruginosa diseases
|
|
3,101
|
| 28461 |
6FABA
|
|
decreases_activity of
|
P. aeruginosa infection
|
in a thermal injury mice model
|
| 28462 |
6CABA
|
|
decreases_activity of
|
P. aeruginosa infection
|
in a thermal injury mice model
|
| 28463 |
4CABA
|
|
decreases_activity of
|
P. aeruginosa infection
|
in a thermal injury mice model
|
|
17941706
|
Pseudomonas aeruginosa diseases
|
|
3,118
|
| 28692 |
bacterial membrane vesicle fusion with host cell membrane
|
|
increases_activity of
|
P. aeruginosa infection
|
|
|
19360133
|
Pseudomonas aeruginosa diseases
|
|
3,121
|
| 28682 |
cif
|
|
increases_activity of
|
P. aeruginosa infection
|
|
|
19360133
|
Pseudomonas aeruginosa diseases
|
|
3,140
|
| 28915 |
P. aeruginosa infection
|
|
decreases_activity of
|
establishment of skin barrier
|
of mucosal surface
|
| 28917 |
P. aeruginosa infection
|
|
decreases_activity of
|
establishment of epithelial cell polarity
|
|
| 28918 |
N-glycan
|
|
increases_activity of
|
P. aeruginosa infection
|
at the apical surface
|
| 28919 |
heparan sulfate proteoglycans, HSPGs
|
|
increases_activity of
|
P. aeruginosa infection
|
at the basolateral surface
|
| 28920 |
P. aeruginosa infection
|
|
affects_activity of
|
phosphatidylinositol 3-kinase signaling
|
|
| 28922 |
P. aeruginosa infection
|
|
increases_activity of
|
morphogenesis of an epithelial bud
|
protrusions are deficient in apical markers and contain basolateral markers
|
|
21747810
|
Pseudomonas aeruginosa diseases
|
HoPaCI